BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nisoldipine

A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.

297+ PubMed studies analyzed · 70 RCTs · Evidence Score: 52.4

Research Domains

Nisoldipine has been studied across 16 research domains including ❤️ Cardiovascular, 🦴 Bone & Joint, 🧠 Focus & Attention, 🫘 Kidney, 🔥 Metabolic. The primary research focus is ❤️ Cardiovascular with 57% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nisoldipine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Simvastatin
36 shared targets
Ethinyl
38 shared targets
Flutamide
32 shared targets
Oxyphenbutazone
33 shared targets
Lovastatin
34 shared targets
Loratadine
33 shared targets
Vitamin
34 shared targets
Melphalan
29 shared targets
17
27 shared targets
Ciclopirox
27 shared targets
Loading evidence profile...

This evidence profile for Nisoldipine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.